ID

34263

Descripción

Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies; ODM derived from: https://clinicaltrials.gov/show/NCT01251757

Link

https://clinicaltrials.gov/show/NCT01251757

Palabras clave

  1. 16/1/19 16/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

16 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus NCT01251757

Eligibility Diabetes Mellitus NCT01251757

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 40-80 years as of time of randomization.
Descripción

ID.1

Tipo de datos

boolean

two or more medication dispensings for any prescription medication from a kp outpatient pharmacy during the baseline year.
Descripción

ID.2

Tipo de datos

boolean

flagged in kp's databases as having either diabetes or atherosclerotic cardiovascular disease(defined as coronary artery disease, peripheral vascular disease, or a history of atherosclerotic stroke)
Descripción

ID.3

Tipo de datos

boolean

continuous membership in kp for the 12 months prior to randomization.
Descripción

ID.4

Tipo de datos

boolean

willing to participate in the study.
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence in the emr of allergy or intolerance to statins, ace inhibitors/arbs,or aspirin
Descripción

ID.6

Tipo de datos

boolean

use of warfarin or other antiplatelet agents for which aspirin use is contraindicated
Descripción

ID.7

Tipo de datos

boolean

end-stage renal disease or other conditions for which ace inhibitor or arb use is contraindicated
Descripción

ID.8

Tipo de datos

boolean

use of medications for which use of statins is contraindicated
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Diabetes Mellitus NCT01251757

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
aged 40-80 years as of time of randomization.
boolean
ID.2
Item
two or more medication dispensings for any prescription medication from a kp outpatient pharmacy during the baseline year.
boolean
ID.3
Item
flagged in kp's databases as having either diabetes or atherosclerotic cardiovascular disease(defined as coronary artery disease, peripheral vascular disease, or a history of atherosclerotic stroke)
boolean
ID.4
Item
continuous membership in kp for the 12 months prior to randomization.
boolean
ID.5
Item
willing to participate in the study.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
evidence in the emr of allergy or intolerance to statins, ace inhibitors/arbs,or aspirin
boolean
ID.7
Item
use of warfarin or other antiplatelet agents for which aspirin use is contraindicated
boolean
ID.8
Item
end-stage renal disease or other conditions for which ace inhibitor or arb use is contraindicated
boolean
ID.9
Item
use of medications for which use of statins is contraindicated
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial